Assessment of antiretroviral treatment outcome in public hospitals, South Nations Nationalities and Peoples Region, Ethiopia

Ethiopian Journal of Health Development

Volumn 25, Issue 2, 2011, Pages 102-109

  Tsegaye, Eyuel ^a   Worku, Alemayehu ^b  

^a Addis Ababa University ^*  (Ethiopia)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856949930     PISSN: 10216790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. FMOH. Aids in Ethiopia: Sixth Report, National HIV/AIDS Prevention and Control Program in Ethiopia. Addis Ababa, 2007.
2. FMOH. Health and health related indicators of 1999 E.C/2008, FMOH. Addis Ababa, 2008.
3. FMOH. Guideline for antiretroviral treatment in adults and adolescents. Addis Ababa, 2007.
4. Assefa Y, Jerene D, Lulseged S, Ooms G, Van Damme W. Rapid scale up of antiretroviral treatment in Ethiopia: Success and System wide effects, PLoS Med Vol. 6, issue 4, 6(4): e1000056. doi: 10.1371/journal.pmed.1000056.
5. Abraham J, Graham S, Till B, Angelique K, Frank T, Marie-Louise N. Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa. Geneva: WHO; 2009; 87: 754-762. doi: 10.247/ BLT .08.058982.
6. Andrew B, Peter B, Meg O, Karen C, Liezl C, Katherine H, et al: Antiretroviral therapy and early mortality in South Africa. Bulletin of WHO, September 2008;86(9).
7. Stephen D, Anthony D, Xavier A, Landon M, Robin W. Early mortality among adults accessing antiretroviral treatment programs in sub-Saharan Africa. AIDS 2008; 22:1897-1908.
8. Zachariah R, Fitzgerald M, Massaquoi M, Pasulani O, Arnould L, Makombe S, Harries AD. Risk factors for high early mortality in patients on antiretroviral treatment in a rural district of Malawi. AIDS 2006; 20: 2355-2360.
9. Evan W, Robert S, Benita Y, Richard H, Michael V. Julio SG. Is there a baseline CD4 cell count that precludes a survival response to modern antiretroviral therapy. AIDS 2003; 17:711-720.
10. Paul J, Samuel M, Raymond M, Catherine S, Gideon R, Robert D, et al. Assessment of a pilot antiretroviral drug therapy program in Uganda: Patients' response, survival and drug resistance. The Lancet 2002;360(9326):34-40.
11. Sikhamani R, Lakshmanan J, Sundaraj V, Chandrahasan G, Krishnaraj R. Predicator of failure of first line antiretroviral therapy in HIV infected adults: India experience. AIDS 2007; 21(Suppl 4):S47-S53.
12. Jeffrey SA, Isaac Z, Jens L, Elizabeth M, Albert M, Benjamin HC, et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia, feasibility and early outcome. JAMA 2006; 296(7); 782-793.
13. Benjamin H Chi, Ronald A, Issac Z, Lloyd B, Jens W, Bushimbwa C, Stewart R, et al. Adherence to first line antiretroviral therapy affects non-virologic outcomes among patients on treatment for more than 12 months in Lusaka, Zambia. International Journal of Epidemiology 2009, 38:746-756.
14. Andrew B, Gilles VC, Karen C, Katherine H, Shaheed M, Musaed A, et al. Outcomes of Nevirapine - and Efavirenz- based antiretroviral therapy when co-administered with Rifampicinbased anti-tubercular therapy. JAMA 2008; 300(5)530-539.
15. Kara W, Silvester K, Lameck D, Abraham S, John S, Constantin T, et al. Viability and effectiveness of large-scale initiatives in sub-Saharan Africa: experience from western Kenya. AIDS 2006;20:41-48.
16. Alexandra C, Lorextu P, Elisabeth S, Elisabeth S, Rony Z, Nathan F, et al. Generic fixed combination antiretroviral treatment in resource-poor settings: Multi-centric observational cohort. AIDS 2006; 20: 1163-1169.
17. Bisola O, Hui Z, Rochelle P, Zhigang L, Elena L, Janet G, et al. Predicators of mortality in patients initiating antiretroviral therapy in Durban, South Africa, NIH manuscript. S Afr Med J 2008;98(3):204-208.
18. Isidore S, Mohamadou S, Anne-Marie S, Joris M, Marleen B, et al. Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the Far-North province, Cameroon. Tropical Medicine and International Health 2009; 14(1): 36-43.
19. Jerene D, Endale A, Hailu Y, Bernt L. Predicators of early death in a cohort of Ethiopia patients treated with HAART, Arba Minch Hospital, Ethiopia BMC infectious Disease, Bio Med Central 2006;6:136.
20. Jerene D. HIV Antiretroviral therapy in Ethiopia overcoming implementation challenges, thesis as a partial fulfillment for of Phd degree at the University of Bergen, Norway, 2007.
21. Stephen D, Anthony D, Xavier A, Landon M. Early mortality among adults accessing antiretroviral treatment programs in sub-Saharan Africa. AIDS 2008; 22:1897-1908.
22. David C, Katherine H, Andrew B, Gary M, Francoise L, Veliswa L, et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 2004;18:887-895.
23. Siaka T, Bertin K, Catherine S, Moussa T, Nicole D, Julien D, et al. Rapid scaling-up of antiretroviral therapy in 10,000 adults in Cote D'Ivoire: 2-year outcomes and determinants, AIDS 2008;22:873-882.
24. Boulle A, Ford N. Scaling up antiretroviral therapy in developing countries: What are the benefits and challenges?, Post Graduate Medical Journal 2008;84:225-227.
25. Molla M. Assessment of quality of antiretroviral therapy (ART) services in the defense hospitals in Addis Ababa and Debrezeit. Masters thesis, AAU, 2008.
26. Awel M. Antiretroviral treatment adherence and its determinants among people living with HIV AIDS on highly active antiretroviral therapy at two hospitals in Oromiya Regional State. Masters thesis, AAU, 2007.
27. Yoann M, Elisabeth S, Christine G, Laurent F, Suna B, Mar P, et al. Weight gain at 3 months of antiretroviral therapy is strongly associated with survival: Evidence from two developing countries. AIDS 2009; 23:853-861.
28. Elvin H, Nneka E, Mwebesa B, David V. Samplingbased approach to determine outcomes of patients lost to follow up in antiretroviral therapy scale up program in Africa. JAMA 2008; 300(5):506-507.